Skip to search formSkip to main contentSkip to account menu

Transurethral Resection of Bladder Tumor

A surgical procedure used to treat bladder tumors, during which a resectoscope is passed through the urethra and into the bladder.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Short term complications from transurethral resection of bladder tumor.
INTRODUCTION The diagnosis and subsequent management of bladder cancer often involves transurethral resection of bladder tumor… 
Highly Cited
2014
Highly Cited
2014
Is en-bloc transurethral resection of bladder tumor for non-muscle invasive bladder carcinoma better than conventional technique in terms of recurrence and progression?: A prospective study
Purpose: Conventional, transurethral resection of bladder tumor (TURBT) involves piecemeal resection of the tumor and has a very… 
Highly Cited
2014
Highly Cited
2014
En bloc transurethral resection with 2-micron continuous-wave laser for primary non-muscle-invasive bladder cancer: a randomized controlled trial
AbstractPurposeTo evaluate the practicability of en bloc transurethral resection with 2-micron continuous-wave laser as treatment… 
Review
2013
Review
2013
Immediate post-transurethral resection of bladder tumor intravesical chemotherapy prevents non-muscle-invasive bladder cancer recurrences: an updated meta-analysis on 2548 patients and quality-of…
Highly Cited
2012
Highly Cited
2012
Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience.
Highly Cited
2011
Highly Cited
2011
Dynamic real-time microscopy of the urinary tract using confocal laser endomicroscopy.
Highly Cited
2007
Highly Cited
2007
Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection.
Highly Cited
2006
Highly Cited
2006
Radiochemotherapy after transurethral resection for high-risk T1 bladder cancer: an alternative to intravesical therapy or early cystectomy?
PURPOSE For high-risk T1 bladder cancer, the most important issue is how to restrict radical cystectomy to selective patients… 
Highly Cited
2006
Highly Cited
2006
Should we screen for bladder cancer in a high‐risk population?
The U.S. Food and Drug Administration recently approved screening high‐risk patients for bladder cancer using urine‐based markers… 
Review
2003
Review
2003
RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination…
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)